The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy

Heinen, Florian; Desloovere, Kaat; Schroeder, A Sebastian; Berweck, Steffen; Borggraefe, Ingo; van Campenhout, Anya; Andersen, Guro L; Aydin, Resa; Becher, Jules G; Bernert, Günther; Caballero, Ignacio Martinez; Carr, Lucinda; Valayer, Emmanuelle Chaleat; Desiato, Maria Teresa; Fairhurst, Charlie; Filipetti, Paul; Hassink, Ralph-Ingo; Hustedt, Ulf; Jozwiak, Marek; Kocer, Serdar Ibrahim; ... (2010). The updated European Consensus 2009 on the use of Botulinum toxin for children with cerebral palsy. European journal of paediatric neurology, 14(1), pp. 45-66. Oxford: Elsevier 10.1016/j.ejpn.2009.09.005

Full text not available from this repository. (Request a copy)

An interdisciplinary European group of clinical experts in the field of movement disorders and experienced Botulinum toxin users has updated the consensus for the use of Botulinum toxin in the treatment of children with cerebral palsy (CP). A problem-orientated approach was used focussing on both published and practice-based evidence. In part I of the consensus the authors have tabulated the supporting evidence to produce a concise but comprehensive information base, pooling data and experience from 36 institutions in 9 European countries which involves more than 10,000 patients and over 45,000 treatment sessions during a period of more than 280 treatment years. In part II of the consensus the Gross Motor Function Measure (GMFM) and Gross Motor Function Classification System (GMFCS) based Motor Development Curves have been expanded to provide a graphical framework on how to treat the motor disorders in children with CP. This graph is named "CP(Graph) Treatment Modalities - Gross Motor Function" and is intended to facilitate communication between parents, therapists and medical doctors concerning (1) achievable motor function, (2) realistic goal-setting and (3) treatment perspectives for children with CP. The updated European consensus 2009 summarises the current understanding regarding an integrated, multidisciplinary treatment approach using Botulinum toxin for the treatment of children with CP.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine

UniBE Contributor:

Steinlin, Maja

ISSN:

1090-3798

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:07

Last Modified:

17 Mar 2015 19:07

Publisher DOI:

10.1016/j.ejpn.2009.09.005

PubMed ID:

19914110

Web of Science ID:

000273943400005

URI:

https://boris.unibe.ch/id/eprint/182 (FactScience: 196654)

Actions (login required)

Edit item Edit item
Provide Feedback